[Inflammatory bowel diseases--new therapeutic options]

[Inflammatory bowel diseases--new therapeutic options] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Inflammatory bowel diseases--new therapeutic options] Abstract Text:

[Inflammatory bowel diseases--new therapeutic options] Publishing Authors By Initials

For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

PUBMED ID PMID:

MEDLINE DATE:

[Inflammatory bowel diseases--new therapeutic options] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Medizinische Klinik (Munich, Germany : 1983)

VOLUME: 103

Page Numbers: 90-101; quiz 102-3

Journal Abbreviation: Med. Klin. (Munich)

ISSN: 0723-5003

DAY: 15

MONTH: Feb

YEAR: 2008

[Inflammatory bowel diseases--new therapeutic options] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 8303501

[Inflammatory bowel diseases--new therapeutic options] Keywords Mesh Terms:

KEYWORDS: Treatment Outcome

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: [Inflammatory bowel diseases--new therapeutic options] Information

Substance Name: infliximab

Registry Number: 0

Grant and Affiliation Information for [Inflammatory bowel diseases--new therapeutic options]

AFFILIATION: Zentrum für Innere Medizin I, Robert-Bosch-Krankenhaus, Auerbachstrasse 110, Stuttgart. klaus.herrlinger@rbk.de

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Med Klin (Munich)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Inflammatory bowel diseases--new therapeutic options Related Publications

• An appreciative inquiry approach to practice improvement and transformative change in health care settings.
• Association of intervention outcomes with practice capacity for change: Subgroup analysis from a group randomized trial.
• Cholesterol reduction using psyllium husks - Do gastrointestinal adverse effects limit compliance? Results of a specific observational study.
• Crohn's disease-Defect in innate defence.
• Curiosity and context revisited: crassulacean acid metabolism in the Anthropocene.
• Directional selectivity in the simple eye of an insect.
• GC-R-CF-MS method to determine the 13C abundance of gaseous combustion products in cigarette smoke.
• How effective is natalizumab induction therapy in patients with Crohn's disease?
• Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease.
• The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4.
• The promise and pitfalls of generalism in achieving the Alma-Ata vision of health for all.
• [A contribution to the histogenesis of the hilus cells.]
• [A contribution to the normal and pathological anatomy of the ovarian rete.]
• [AM I REALLY STUPID?EXCERPTS FROM A PSYCHAGOGIC TREATMENT.]
• [Comparative morphological studies on the fallopian tube in its maximal functional state to clarify the question of an existing infundibular sphincter?]
• [Disgerminoma and intersexuality.]
• [Experimental study on labor readiness and possibilities of its control.]
• [Inflammatory bowel diseases--new therapeutic options]
• [Is the small step method useful to us? Productivity Training Corporation (PTC) from the users' viewpoint]
• [Recurring glomus tumors of the preputium clitoridis.]
• [Stoma care service is required in Norway]
• [Therapy of chronic inflammatory bowel diseases]
• [Tumor development in gonadal abnormalities & its significance for therapeutic progress.]
• [Value of stimulation-excitation lines acoustically evoked for speech discrimination in children]